▲ BUY
10
/ 10
Conviction
$ Value
$1.6M
Shares
50,000
Price
$33
Filed
Mar 2
▶ Why this score? (10/10)
- ✓ Open market buy (+3)
- ✓ Trade value >= $1.0M (+2)
- ✓ % of holdings >= 50% (+3)
- ✓ Director (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Stein Jeffrey
Title
—
CIK
0001478831
Roles
Director
Transaction Details
Transaction Date
2026-03-02
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
54,281
Footnotes
This transaction was executed in multiple trades in prices ranging from $32.743 to $33.1999, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.
Filing Info
Stein Jeffrey's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-02 | IDYA | ▲ | $1.6M ★ |
| 2026-01-07 | CDTX | D | $1.3M |
| 2026-01-07 | CDTX | D | $527K |
| 2026-01-07 | CDTX | D | $15.0M |
| 2026-01-07 | CDTX | D | — |
| 2026-01-07 | CDTX | D | — |
| 2026-01-07 | CDTX | D | — |
| 2026-01-07 | CDTX | D | — |
| 2026-01-07 | CDTX | D | — |
| 2026-01-07 | CDTX | D | — |
Other Insiders at IDYA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Beaupre Darrin
Chief Medical Officer
|
— | — | 2026-01-30 |
|
Hata Yujiro S
President and CEO
|
— | — | 2026-01-30 |
|
Snyder Douglas B.
SVP, General Counsel
|
— | — | 2026-01-30 |
|
WHITE MICHAEL ANTHONY
Chief Scientific Officer
|
— | — | 2026-01-30 |
|
Ruiz Briseno Andres
See Remarks
|
— | — | 2026-01-30 |
|
DORMAN STUART
Chief Commercial Officer
|
— | — | 2026-01-30 |
|
Bleharski Joshua
Chief Financial Officer
|
— | — | 2026-01-30 |